Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q8IZ52
UPID:
CHSS2_HUMAN
Alternative names:
Chondroitin glucuronyltransferase 2; Chondroitin-polymerizing factor; Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II; N-acetylgalactosaminyltransferase 2
Alternative UPACC:
Q8IZ52; B4DXU0; Q6UXD6; Q7L4G1; Q9H0F8; Q9H618
Background:
Chondroitin sulfate synthase 2, known by alternative names such as Chondroitin glucuronyltransferase 2 and N-acetylgalactosaminyltransferase 2, plays a crucial role in the biosynthesis of chondroitin sulfate. This enzyme exhibits beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity, essential for transferring glucuronic acid and N-acetylgalactosamine to the chondroitin polymer. It acts as a specific activating factor for CHSY1 in chondroitin polymerization, highlighting its significance in cellular structures.
Therapeutic significance:
Understanding the role of Chondroitin sulfate synthase 2 could open doors to potential therapeutic strategies. Its involvement in the synthesis of chondroitin sulfate, a key component of the extracellular matrix, suggests its potential in treating diseases related to cellular structure and function.